Welcome to the News Room

What does the “London Declaration on Neglected Tropical Diseases” reveal about research and development efforts into neglected and tropical diseases?

Posted by:

Earlier this week the Gates Foundation, USAID, DfID, the WHO, DNDi, the Governments of Mozambique, Tanzania, Brazil and a host of multinational biopharmaceutical manufacturers including GlaxoSmithKline, Merck, Eisai, Johnson & Johnson, Sanofi, Novartis, Bayer and Abbott, committed to eradicate and control a number of neglected and tropical diseases (NTDs).

This brief will examine the declaration, the pledges made and the methods to be used. For more details click here


About the Author:

Prof. Meir Pugatch specialises in intellectual property policy, management and exploitation of knowledge assets, technology transfer, market access, pharmacoeconomics and political economy of public health systems. He has extensive experience in economic and statistical modelling and indexing; valuation of assets and design of licensing agreements; and providing strategic advice to international institutions, multinational corporations and SMEs from all sectors of the knowledge economy. Meir’s work is highly international and he has wide-ranging knowledge of North America, Europe, Asia and the Middle East.
  Related Posts
  • No related posts found.